Physician profile
Tara A Quesnell
NPI 1619288172
$14,247.15
in general payments reported to CMS, 2019-2025
73 companies · $3,507 in 2025
The $3,507 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,037 · 2020: $902 · 2021: $1,646 · 2022: $1,216 · 2023: $2,160 · 2024: $2,780 · 2025: $3,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,446.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,664.66 | 2021-2025 | |
| Ucb, INC. | $1,280.75 | 2019-2025 | Zilbrysq, Briviact, Nayzilam |
| Argenx US, INC. | $655.01 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Sk Life Science, INC. | $637.38 | 2020-2025 | |
| Allergan, INC. | $558.49 | 2019-2022 | |
| Biogen, INC. | $489.79 | 2019-2025 | Spinraza, Qalsody, Leqembi |
| Pfizer INC. | $424.40 | 2023-2025 | |
| Csl Behring | $400.69 | 2019-2025 | Hizentra |
| Jazz Pharmaceuticals INC. | $396.41 | 2019-2025 | |
| Lundbeck LLC | $394.53 | 2019-2025 | Vyepti |
| Alexion Pharmaceuticals, INC. | $387.72 | 2019-2025 | Ultomiris |
| Takeda Pharmaceuticals U.S.A., INC. | $377.28 | 2023-2025 | Hyqvia, Gammagard |
| Novartis Pharmaceuticals Corporation | $360.08 | 2019-2025 | |
| Lilly USA, LLC | $341.47 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $263.28 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Quesnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.